Miles

Executive Summary

Forms Biological Products unit and new Biotechnology Business unit headed by Ralph Galustian and George Scangos, PhD, respectively. Galustian will continue in his current role as president of the expanded Biological Products unit, which is part of the Miles Pharmaceutical Division based in West Haven, Conn., company announces Sept. 9. The unit will have global responsibility for manufacturing and creating international strategic marketing partnerships for plasma-derived products and biotechnologically derived products. The unit, which employs 1,700 people, has manufacturing sites in Clayton, N.C., Berkeley and Covina, Calif. and Spokane, Wash. and annual sales of about $500 mil. The new biotech business unit, with offices in Berkeley and West Haven, will bring together research institutes formerly spread throughout Miles and its German parent Bayer AG, and will be responsible for licensing R&D and production of all biotech products. The biotechnology unit employs 1,100 people. The reorganization becomes effective Oct. 1.